Patent classifications
A01N37/44
USE OF PICOLINAMIDES AS FUNGICIDES
This disclosure relates to picolinamides of Formula I and their use as fungicides.
##STR00001##
PATHOGEN-INACTIVATED RED BLOOD CELL COMPOSITIONS
The present invention provides pathogen-inactivated red blood cell compositions.
PATHOGEN-INACTIVATED RED BLOOD CELL COMPOSITIONS
The present invention provides pathogen-inactivated red blood cell compositions.
PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules, and processes of using such molecules against such pests. These molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses molecules having the following formula (“Formula One”).
##STR00001##
COMPOSITIONS OF SAPONINS AND PLANT EXTRACTS
Provided are compositions including saponins and plant extracts having an antimicrobial activity.
COMPOSITIONS OF SAPONINS AND PLANT EXTRACTS
Provided are compositions including saponins and plant extracts having an antimicrobial activity.
USE OF ALGINATES OLIGOMERS TO IMPROVE PLANT PROTECTION AGAINST PATHOGENS
The invention concerns the use of alginate oligomers in sequence α(1-4)Guluronane and/or β(1-4)Mannuronane having a DP greater than 30, as an active ingredient of biocontrol products in plants, and that may be combined with another molecules such as phytohormones, against cryptogamic diseases of plants, in particular of vine (Vitis vinifera), or to protect other species against aggressors such as pathogenic microbes or insects.
USE OF ALGINATES OLIGOMERS TO IMPROVE PLANT PROTECTION AGAINST PATHOGENS
The invention concerns the use of alginate oligomers in sequence α(1-4)Guluronane and/or β(1-4)Mannuronane having a DP greater than 30, as an active ingredient of biocontrol products in plants, and that may be combined with another molecules such as phytohormones, against cryptogamic diseases of plants, in particular of vine (Vitis vinifera), or to protect other species against aggressors such as pathogenic microbes or insects.
Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals
The present invention pertains to the use for preventing or treating intestinal infections caused by gram-positive bacteria in animals of an antibacterial compound selected from lactylate in accordance with formula 1,
R2—COO—[—CH(CH.sub.3)—COO].sub.n—R1 Formula 1
or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, a glycolylate of formula 2,
R2—COO—[—CH2—COO].sub.n—R1 Formula 2
or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, a lactate ester of formula 3,
HO—CH(CH.sub.3)—COO—R22 Formula 3
and/or a glycolic acid ester of formula 4,
HO—CH2—COO—R2 Formula 4
wherein R1 is selected from H, n stands for an integer with a value of 1-10, and R2 stands for a C1-C35 alkyl or alkenyl chain which may be branched or unbranched. The compound, which preferably is a lactylate or a Na, K, Ca, Mg, Fe(II), Zn, NH.sub.4, or Cu(II) salt thereof, is particularly useful in the treatment or prevention of Clostridia. An animal nutrition composition and a method for preventing or treating infections are also claimed.
Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex
The invention provides compounds for use in inhibiting a microbial alternative oxidase (AOX) and/or cytochrome bc.sub.1 complex. The invention extends to the use of such inhibitors in agrochemicals and in pharmaceuticals, for treating microbial infections, including fungal infections.